|
1. Domain: health descriptors |
|
Evaluation |
Instruments |
History—Level 0 |
Sociodemographic inventory |
History—Level 1 |
Family medical history |
|
Personal medical history |
|
Medication, hormone use, and alternative treatments |
|
Immunization history |
History—Level 2 | |
History—Level 3 | |
Examination—Level 0 | |
Examination—Level 1 | |
Examination—Level 2 | |
Examination—Level 2 | |
|
2. Domain: cognition |
|
Evaluation |
Instruments |
History—Level 0 |
Screening for cognitive problems |
History—Level 1 |
Cognitive reserve (CR) |
History—Level 2 |
(i) Cognitive risk factors |
|
(ii) Cognitive reserve adjusted for cognitive risk (CRar) |
|
(iii) Stage of change, objective [17] |
History—Level 3 |
Global cognitive reserve (gCR) |
Examination—Level 0 | |
Examination—Level 1 | |
Examination—Level 2 |
7-minute test [19, 20] |
Examination—Level 3 |
(i) Luria’s test [21] |
|
(ii) Benton’s visual recognition test [22] |
|
(iii) Trail making test-A (TMT-A) [23] |
|
(iv) Finger electronic tapping test (FETT) [24] |
|
3. Domain: vitalty and stress |
|
Evaluation |
Instruments |
History—Level 0 |
Screening for emotional state |
History—Level 1 |
(i) Optimism-LOT-R: life orientation test-revised [25] |
|
(ii) Emotional stress—Questions 5–9, SF-36: social functioning-36 question scale [26, 27]/MHI-5. |
|
(iii) Social isolation—STAKES [28] |
|
(iv) Social support—Oslo [29] |
|
(v) Anxiety/depression—HAD: hospital anxiety and depression scale [30] |
History—Level 2 |
(i) NEO Pi-R: revised NEO personality inventory [31] |
|
(ii) Psychological well-being [32, 33] |
|
(iii) Sexuality quality of life: sexuality subscales [34, 35] |
|
(iv) Stress—HAD [30, 36] |
|
(v) Stage of change, objective [17] |
History—Level 3 |
(i) Social readjustment rating scale [37] |
|
(ii) Type A personality—ERCTA: escala retiro de patrón de conducta tipo A (scale of Type A behavior pattern) [38] |
|
(iii) Aggression subscale—ZKPQ: Zuckerman-Kuhlman’s personality questionnaire [39] |
|
(iv) Obsessions—SPPI: standardized polyvalent psychiatric interview [40] |
|
(v) Hypochondriasis—SPPI [40] |
|
(vi) Gender-specific medical evaluation, including breast cancer risk assessment [41] |
Examination—Level 0 | |
Examination—Level 1 | |
Examination—Level 2 |
Basic allostatic load: blood pressure, waist-to-hip ratio, total/HDL cholesterol, HDL, glycated hemoglobin, CRP |
Examination—Level 3 |
Expanded allostatic load: add DHEA-S and urinary cortisol |
|
4. Domain: sleep |
|
Evaluation |
Instruments |
History—Level 0 |
Screening for insomnia and hypersomnia |
History—Level 1 |
(i) Insomnia—SPPI [40] |
|
(ii) Somnolence—Epworth sleepiness scale [42–44] |
|
(iii) Specific sleep-related symptoms |
|
(iv) Sleep habits |
History—Level 2 |
Stage of change, objective [17] |
History—Level 3 | |
Examination—Level 0 | |
Examination—Level 1 | |
Examination—Level 2 | |
Examination—Level 3 |
Polysomnography |
|
5. Domain: diet and exercise |
|
Evaluation |
Instruments |
| Instruments DIET | Instruments EXERCISE |
History—Level 0 | Screening for change in appetite (SSPI) | Activity level |
History—Level 1 | Eating habits | Exercise habits |
| Table of mealtimes | Exercise readiness—Par-Q: physical activity readiness questionnaire [45] |
| Appetite-SPPI [40] | Fatigue-adapted SPPI [40] |
| Subclassification BMI | Estimated METs |
|
Metabolic classification (combines weight status and activity level) (16 levels) |
|
Classification as recommendations: 5 levels |
| Readiness to change—diet and exercise—subjective | Readiness to change—diet and exercise—objective |
History—Level 2 | CFCA-food frequency questionnaire [46] | |
| Digestive symptoms, food intolerance, dental problems | Musculoskeletal physical barriers to exercise |
| Readiness to change—diet and exercise—objective | Readiness to change—diet and exercise—objective |
History—Level 3 | | |
Examination—Level 0 |
(i) Waist circumference |
|
(ii) Reported body mass index (BMI) from reported weight and height |
Examination—Level 1 |
(i) Body composition—subclassification BMI |
|
(ii) Waist-to-hip ratio |
|
(iii) BMI adjusted for waist circumference [47], (BMIa) |
Examination—Level 2 |
(i) Basic lab work: total/HDL cholesterol, HDL, glycated hemoglobin, C-reactive protein, microalbumin, glucose, insulin |
|
(ii) Blood pressure, heart rate. |
|
(iii) Adjusted BMI (for adult weight gain, triglyceride/HDL, blood pressure, fasting glucose, and presence or absence of sleep apnea and osteoarthritis (BMIar)) |
|
(iv) Body composition (triceps skin fold), estimated muscle mass (arm circumference) |
|
(v) Insulin resistance-HOMA-IR [48] |
Examination—Level 3 | 3-day food record analyzed by nutritionist | Indirect METs calculated through compendium of physical activities—CPHA [49] |
| | Hand strength via dynamometry |
| (i) Body composition via BIA or DEXA | (i) Somatometry |
| (ii) Nutritional calculator | (ii) Ergometry |
| | (iii) Direct METs measurement |
|
6. Domain: substance abuse |
|
Evaluation |
Instruments |
History—Level 0 |
Screening for substance abuse |
History—Level 1 |
Inventory: use and abuse of prescription medications, use of caffeine, nicotine, alcohol, and illicit drugs |
|
Adapted CAGE questionnaire for each substance [50, 51] |
|
Stage of change for each substance, subjective |
History—Level 2 |
(i) Stage of change for each substance, objective |
|
(ii) For smokers: Fagerström’s test of nicotine dependence [52, 53] |
History—Level 3 | |
Examination—Level 0 | |
Examination—Level 1 | |
Examination—Level 2 | |
Examination—Level 3 |
Nicotine—CO-oximetry |
|
Alcohol—GGT, MCV |
|
Drug levels in urine/blood/hair tests |
|
7. Domain: other risk habits |
|
Evaluation |
Instruments |
History—Level 0 | |
History—Level 1 |
(i) Medication adherence. |
|
(ii) Inventory of risk behaviors: risky sexual behavior, dangerous sports, gambling, dangerous driving, potentially dangerous travel, internet/technology addiction. |
|
(iii) Readiness to change—subjective |
History—Level 2 |
Readiness to change—objective |
History—Level 3 | |
Examination—Level 0 | |
Examination—Level 1 | |
Examination—Level 2 | |
Examination—Level 3 | |
|